Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Oct 3, 2018 | Main Blog |
The drug development model is in need of a drastic shakeup. COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic...
Recent Comments